Go Deep
Gujarat Kidney And Super Speciality Limited
Gujarat Kidney And Super Speciality Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,865 | 97.3 | 6.08 | 0.11 | 194.65 |
| Oct 2026 | 21,271 | 97.1 | 6.07 | 0.11 | 194.27 |
| Oct 2026 | 21,353 | 72.5 | 5.75 | 0.11 | 184.09 |
Gujarat Kidney And Super Speciality Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Jun 2025 |
|---|---|---|---|---|
| Revenue | 342,892,000.0 | 305,785,000.0 | 232,459,000.0 | 152,602,000.0 |
| Net Profit | 51,815,000.0 | 50,419,000.0 | 29,415,000.0 | 48,448,000.0 |
| EPS | 0.7 | 0.8 | 0.5 | 0.6 |
Gujarat Kidney And Super Speciality Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | 605,983,000.0 | 367,794,000.0 | 1,034,415,000.0 | 857,919,000.0 |
| Net Profit | 154,969,000.0 | 94,131,000.0 | 96,839,000.0 | 66,359,000.0 |
| EPS | 2.5 | 1.2 | 1.2 | 0.8 |
Gujarat Kidney And Super Speciality Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Total Assets | 2,976,400,000.0 | 553,447,000.0 | 653,976,000.0 | 638,591,000.0 |
| Total Liabilities | 429,045,000.0 | 282,183,000.0 | 425,480,000.0 | 415,595,000.0 |
| Total Equity | 2,525,122,000.0 | 259,362,000.0 | 222,692,000.0 | 219,587,000.0 |
Owes vs Owns
Gujarat Kidney And Super Speciality Limited owed ₹0.14 for every ₹1 it owned in Mar 2026, down from ₹0.65 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.14× | 0.51× | 0.65× | 0.65× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Gujarat Kidney And Super Speciality Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 18.9%Receivables 13.0%Inventory 0.7%Fixed assets (tangible) 32.5%Intangible assets 30.5%Long-term investments 0.8%Other assets 3.7%
How it's funded — Mar 2026
Short-term debt 4.7%Long-term debt 0.6%Payables 2.8%Other liabilities 6.3%Shareholders' equity 85.6%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 56.1 | 2.8 | 4.4 | 2.2 |
| Receivables | 38.6 | 15.2 | 15.5 | 13.7 |
| Inventory | 2.1 | 0.7 | 1.0 | 0.7 |
| Fixed assets (tangible) | 96.8 | 23.9 | 37.5 | 38.3 |
| Intangible assets | 90.7 | 7.1 | 0.0 | 0.0 |
| Long-term investments | 2.4 | 1.6 | 2.0 | 1.5 |
| Other assets | 10.9 | 4.1 | 5.0 | 7.6 |
| Liabilities & equity | ||||
| Short-term debt | 13.9 | 1.7 | 2.9 | 3.9 |
| Long-term debt | 1.8 | 2.1 | 9.1 | 12.2 |
| Payables | 8.5 | 3.2 | 9.7 | 12.8 |
| Other liabilities | 18.7 | 21.1 | 20.9 | 12.7 |
| Shareholders' equity | 254.7 | 27.1 | 22.8 | 22.3 |
| Net tangible assets | 161.8 | 18.8 | 22.3 | 22.0 |
Gujarat Kidney And Super Speciality Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Operating Activities | -38,617,000.0 | 136,080,000.0 | 12,128,000.0 | 1,000.0 |
| Investing Activities | -2,138,527,000.0 | -181,446,000.0 | 2,233,000.0 | 0.0 |
| Financing Activities | 2,284,008,000.0 | 61,621,000.0 | -4,693,000.0 | 0.0 |